Table 1.
Baseline Demographics of Study Participants, the Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (The SUN Study) and the CNS HIV Antiretroviral Therapy Effects Research (CHARTER) study.
| Characteristic | n=46 n (%) |
|---|---|
| Gender | |
| Male | 33 (72%) |
| Female | 13 (28%) |
| Race | |
| Caucasian | 19 (41%) |
| African American | 26 (57%) |
| Hispanic | 1 (2%) |
| Median age (range) | 40 (21–62) |
| Median years since HIV diagnosis | 5.5 (0.–23) |
| (range) | |
| Education level | |
| Less than HS | 6 (13%) |
| HS/GED | 22 (48%) |
| Some college | 12 (26%) |
| College graduate | 5 (11%) |
| unknown | 1 (2%) |
| Current substance use | |
| Alcohol | 26 (57%) |
| Marijuana | 3 (7%) |
| Cocaine | 2 (4%) |
| IVDU | 1 (2%) |
| Median nadir CD4 count (range) | 255 (0–1020) |
| Nadir CD4 count < 200c/mm3 | 15 (33%) |
| Median current CD4 count (range) | 424.5 (79–1300) |
| On cART | 34 (74%) |
| Median current HIV VL (range) | 136.5 (<50 –309,000) |
| VL range, copies/mL | |
| <400 | 28 (61%) |
| 400–999 | 1 (2%) |
| 1000–9,999 | 6 (13%) |
| 10,000–99,999 | 10 (22%) |
| >100,000 | 1 (2%) |
| Global Deficit Score | |
| Normal | 24 (52%) |
| Mild impairment | 20 (43%) |
| Moderate impairment | 2 (4%) |
HIV=human immunodeficiency virus; HS=high school; GED=general educational development; IVDU=intravenous drug user; VL=viral load.